Research ArticleOriginal Research

CPAP Has No Effect on Clearance, Sputum Properties, or Expectorated Volume in Cystic Fibrosis

Evanirso Silva Aquino, Francine Shimura, Adriana Silveira Santos, Danielle Miyuki Goto, Cristiane Cenachi Coelho, Marcelo Bicalho de Fuccio, Paulo Hilario Nascimento Saldiva, Geraldo Lorenzi-Filho, Bruce K Rubin and Naomi Kondo Nakagawa
Respiratory Care November 2012, 57 (11) 1914-1919; DOI: https://doi.org/10.4187/respcare.01705

References

  1. 1.↵
    1. Boucher RC
    . Evidence for airway surface dehydration as the initiating event in CF airway disease. J Intern Med 2007;261(1):5–16.
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    1. Davis P
    . Cystic fibrosis since 1938. Am J Respir Crit Care Med 2006;173(5):475–482.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Pryor JA,
    2. Webber BA,
    3. Hodson ME,
    4. Warner JO
    . The Flutter VRP1 as an adjunct to chest physiotherapy in cystic fibrosis. Respir Med 1994;88(9):677–681.
    OpenUrlCrossRefPubMed
  4. 4.
    1. Wagner JS,
    2. Headley AA
    . Cystic fibrosis: trends in respiratory care. Respir Care 2003;48(3):234–245.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Rubin BK
    . Mucus structure and properties in cystic fibrosis. Pediatr Respir Rev 2007;8(1):4–7.
    OpenUrl
  6. 6.↵
    1. Darbee JC,
    2. Ohtake PJ,
    3. Grant BJB,
    4. Cerny FJ
    . Physiologic evidence for the efficacy of positive expiratory pressure as an airway clearance technique in patients with cystic fibrosis. Phys Ther 2004;84(6):524–537.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Regnis JA,
    2. Piper AJ,
    3. Henke KG,
    4. Parker S,
    5. Bye PT,
    6. Sullivan CE
    . Benefits of nocturnal nasal CPAP in patients with cystic fibrosis. Chest 1994;106(6):1717–1724.
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    1. Holland AE,
    2. Ntoumenopoulos G,
    3. Naughton MT,
    4. Wilson JW
    . Non-invasive ventilation assists chest physiotherapy in adults with acute exacerbations of cystic fibrosis. Thorax 2003;58(10):880–884.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Smaldone GC
    . Assessing new technologies: patient-device interactions and deposition. Respir Care 2005;50(9):1151–1160.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    American Association for Respiratory Care (AARC) Clinical practice guidelines: use of positive airway pressure adjuncts to bronchial hygiene therapy. Respir Care 1993;38(5):516–521.
    OpenUrlPubMed
  11. 11.↵
    1. Placidi G,
    2. Cornacchia M,
    3. Polese G,
    4. Zanolla L,
    5. Assael BM,
    6. Braggion C
    . Chest physiotherapy with positive airway pressure: a pilot study of short-term effects on sputum clearance in patients with cystic fibrosis and severe airway obstruction. Respir Care 2006;51(10):1145–1153.
    OpenUrlPubMedWeb of Science
  12. 12.↵
    1. Robinson M,
    2. Regnis JA,
    3. Bailey DL,
    4. King M,
    5. Bautovich GJ,
    6. Bye PT
    . Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis. Am J Respir Crit Care Med 1996;153(5):1503–1509.
    OpenUrlPubMedWeb of Science
  13. 13.↵
    1. Schmidt HJ,
    2. Bhandari V,
    3. Bhandari A,
    4. Davies J,
    5. Marshall BC,
    6. Praud JP,
    7. et al
    . The future of paediatric respirology. Respirology 2010;15(5):733–741.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Riedler J,
    2. Reade T,
    3. Button B,
    4. Robertson CF
    . Inhaled hypertonic saline increases sputum expectoration in cystic fibrosis. J Paediatr Child Health 1996;32(1):48–50.
    OpenUrlPubMedWeb of Science
  15. 15.↵
    1. Elkins MR,
    2. Robinson M,
    3. Rose BR,
    4. Moriarty CP,
    5. Marks GB,
    6. Belousova EG,
    7. et al
    . A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med 2006;354(3):229–240.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    1. Bradley J,
    2. McAlister O,
    3. Elborn S
    . Pulmonary function, inflammation, exercise capacity and quality of life in cystic fibrosis. Eur Respir J 2001;17(4):712–715.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Wanger J,
    2. Clausen JL,
    3. Coates A,
    4. Pedersen OF,
    5. Brusasco V,
    6. Burgos F,
    7. et al
    . Standardization of the measurement of lung volumes. Eur Respir J 2005;26(3):511–522.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Solymar L,
    2. Aronsson PH,
    3. Bake B,
    4. Bjure J
    . Nitrogen single breath test, flow-volume curves and spirometry in healthy children, 7-18 years of age. Eur J Respir Dis 1980;61(5):275–286.
    OpenUrlPubMedWeb of Science
  19. 19.↵
    1. Albertini-Yagi CS,
    2. Carvalho-Oliveira R,
    3. Vieira JE,
    4. Negri EM,
    5. de Oliveira LR,
    6. Saldiva PHN,
    7. Lorenzi-Filho G
    . Sputum induction as a research tool for the study of human respiratory mucus. Respir Physiol Neurobiol 2005;145(1):101–110.
    OpenUrlPubMed
  20. 20.↵
    1. King M,
    2. Brock G,
    3. Lundell C
    . Clearance of mucus by simulated cough. J Appl Physiol 1985;58(6):1776–1782.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. Nakagawa NK,
    2. Macchione M,
    3. Petrolino HMS,
    4. Guimarães ET,
    5. King M,
    6. Saldiva PHN,
    7. Lorenzi-Filho G
    . Effects of heated humidifier and heat and moisture exchanger on mucus rheological properties in patients under mechanical ventilation. Crit Care Med 2000;28(2):312–317.
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    1. Puchelle E,
    2. Zahm JM,
    3. Jacquot J,
    4. Plotkowski MC,
    5. Duvivier C
    . A simple technique for measuring adhesion properties of human bronchial secretions. Eur J Respir Dis 1987;71:281–282.
    OpenUrl
  23. 23.↵
    1. Daviskas E,
    2. Anderson SD,
    3. Jacques A,
    4. Charlton B
    . Inhaled mannitol improves the hydration and surface properties of sputum in patients with cystic fibrosis. Chest 2010;137(4):861–868.
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.↵
    1. Bush A,
    2. Payne D,
    3. Pike S,
    4. Jenkins G,
    5. Henke MO,
    6. Rubin BK
    . Mucus properties in children with primary ciliary dyskinesia: comparison with cystic fibrosis. Chest 2006;129(1):118–123.
    OpenUrlCrossRefPubMedWeb of Science
  25. 25.↵
    1. Donaldson SH,
    2. Bennett WD,
    3. Zeman KL,
    4. Knowles MR,
    5. Tarran R,
    6. Boucher RC
    . Mucus clearance and lung function in cystic fibrosis with hypertonic saline. N Engl J Med 2006;354(3):241–250.
    OpenUrlCrossRefPubMedWeb of Science
  26. 26.↵
    1. Baum G,
    2. Priel Z,
    3. Roth Y,
    4. Liron N,
    5. Ostfield E
    1. Rubin BK
    . Surface properties of respiratory secretions: relationship to mucus transport. In: Baum G, Priel Z, Roth Y, Liron N, Ostfield E, editors. Cilia, mucus and mucociliary interactions. New York: Marcel Dekker; 1998:317–323.
  27. 27.↵
    1. Albers GM,
    2. Tomkiewicz RP,
    3. May MK,
    4. Ramirez OE,
    5. Rubin BK
    . Ring distraction technique for measuring the surface tension of sputum and relationship of the work of adhesion to clearability. J Appl Physiol 1996;81(6):2690–2695.
    OpenUrlAbstract/FREE Full Text
  28. 28.↵
    1. Fauroux B,
    2. Boulé M,
    3. Lofaso F,
    4. Zérah F,
    5. Clément A,
    6. Harf A,
    7. Isabey D
    . Chest physiotherapy in cystic fibrosis: improved tolerance with nasal pressure support ventilation. Pediatrics 1999;103(3):E32.
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. Moran F,
    2. Bradley JM,
    3. Piper AJ
    . Non-invasive ventilation for cystic fibrosis. Cochrane Database Syst Rev 2009;21(1):CD002769.
    OpenUrl
  30. 30.↵
    1. Beardsmore CS
    . Lung function from infancy to school age in cystic fibrosis. Arch Dis Childhood 1995;73(6):519–523.
    OpenUrlAbstract/FREE Full Text
  31. 31.↵
    1. Chatmongkolchart S,
    2. Schettino GP,
    3. Dillman C,
    4. Kacmarek RM,
    5. Hess DR
    . In vitro evaluation of aerosol bronchodilator delivery during noninvasive positive pressure ventilation: effect of ventilator settings and nebulizer position. Crit Care Med 2002;30(11):2515–2519.
    OpenUrlCrossRefPubMedWeb of Science
  32. 32.
    1. Hess DR
    . The mask for noninvasive ventilation: principles of design and effects on aerosol delivery. J Aerosol Med 2007;20(1):S85–S99.
    OpenUrlCrossRefPubMedWeb of Science
  33. 33.↵
    1. Dhand R
    . Inhalation therapy in invasive and noninvasive mechanical ventilation. Curr Opin Crit Care 2007;13(1):27–38.
    OpenUrlPubMed
  34. 34.↵
    1. Parkes SN,
    2. Bersten AD
    . Aerosol kinetics and bronchodilator efficacy during continuous positive airway pressure delivered by face mask. Thorax 1997;52(2):171–175.
    OpenUrlAbstract
  35. 35.↵
    1. Chan HK,
    2. Eberl S,
    3. Daviskas E,
    4. Constable C,
    5. Young I
    . Changes in lung deposition of aerosols due to hygroscopic growth: a fast SPECT study. J Aerosol Med 2002;15(3):307–311.
    OpenUrlPubMed
  36. 36.↵
    1. O'Connell OJ,
    2. O'Farrell C,
    3. Harrison MJ,
    4. Eustace JA,
    5. Henry MT,
    6. Plant BJ
    . Nebulized hypertonic saline via positive expiratory pressure versus via jet nebulizer in patients with severe cystic fibrosis. Respir Care 2011;56(6):771–775.
    OpenUrlAbstract/FREE Full Text
Back to top

In this issue

 

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Related Articles

Cited By...

Keywords